Lenacapavir: The Twice-Yearly HIV Prevention Shot
Lenacapavir: The Twice-Yearly HIV Prevention Shot
For decades, HIV prevention meant taking daily pills. But in 2025, everything changed with the FDA approval of Lenacapavir (Yeztugo), the world’s first twice-yearly HIV prevention injection.
In this video, we’ll break down:
✅ How Lenacapavir works to block HIV infection
✅ Why it’s more effective than daily pills for many people
✅ What this breakthrough means for the global fight against HIV
✅ The future of HIV treatment and prevention
π If you’re passionate about medical innovation, subscribe and join us for more health breakthroughs that could change the world.
Comments
Post a Comment